CELL PREPARATIONS DEPLETED OF TCR ALPHA/BETA
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Sep 16, 2013
filing date -
Mar 17, 2011
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to a composition, comprising a cell population that can be obtained from bone marrow or from blood, when the cell population is depleted of cells that express TCR alpha/beta and cells that express CD19. Such a pharmaceutical composition makes the reconstitution of the immune defense of a person as part of a bone marrow transplantation possible. By means of the invention, the time until the immune reconstitution is considerably shortened and the immune response after treatment are considerably reduced, in particular the occurrence of GvHD. The survival rate of the patient is considerably increased.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully